公开(公告)号：WO2011022694A2

公开(公告)日：2011-02-24

申请号：PCT/US2010/046226

申请日：2010-08-20

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE ,  MOORE, Bob, M. II ,  GURLEY, Steven ,  MUSTAFA, Suni

Inventor： MOORE, Bob, M. II ,  GURLEY, Steven ,  MUSTAFA, Suni

IPC: C07D491/048 ,  C07D409/04 ,  A61K31/519 ,  A61P35/00

CPC classification number: C07D491/048

Abstract: Furanopyrimidine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.

Abstract translation: 公开了式I的呋喃并嘧啶大麻素类似物。 该化合物可用于改变CB 1和CB 2受体的活性并治疗由这些受体介导的病症。

公开(公告)号：WO2009143179A1

公开(公告)日：2009-11-26

申请号：PCT/US2009/044557

申请日：2009-05-19

Applicant: UNIVERSIYT OF TENNESSEE RESEARCH FOUNDATION, THE ,  MOORE, Bob, M. ,  GURLEY, Steven ,  MUSTAFA, Suni

Inventor： MOORE, Bob, M. ,  GURLEY, Steven ,  MUSTAFA, Suni

IPC: A01N43/16 ,  A61K31/35

CPC classification number: C07D491/052

Abstract: Disclosed are compounds of the formula I: wherein R 1 , R 2 , V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.

Abstract translation: 公开了式I的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。

公开(公告)号：WO2011022694A3

公开(公告)日：2011-06-16

申请号：PCT/US2010046226

申请日：2010-08-20

Applicant: UNIV TENNESSEE RES FOUNDATION ,  MOORE BOB M II ,  GURLEY STEVEN ,  MUSTAFA SUNI

Inventor： MOORE BOB M II ,  GURLEY STEVEN ,  MUSTAFA SUNI

IPC: C07D491/048 ,  A61K31/519 ,  A61P35/00 ,  C07D409/04

CPC classification number: C07D491/048

Abstract: Furanopyrimidine cannabinoid analog compounds of the formula I are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.

Abstract translation: 公开了式I的呋喃并嘧啶大麻素类似物化合物。 这些化合物可用于修饰CB 1和CB 2受体的活性并治疗由这些受体介导的病症。

公开(公告)号：WO2011022692A2

公开(公告)日：2011-02-24

申请号：PCT/US2010/046222

申请日：2010-08-20

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE ,  MOORE, Bob, M., II ,  GURLEY, Steven ,  MUSTAFA, Suni

Inventor： MOORE, Bob, M., II ,  GURLEY, Steven ,  MUSTAFA, Suni

IPC: C07D491/048 ,  C07D409/04 ,  C07D213/02 ,  A61K31/4355 ,  A61P35/00

CPC classification number: C07D491/04 ,  A61K31/4355

Abstract: Furanopyridine cannabinoid analog compounds of the formula (I) are disclosed. The compounds are useful to modify the activity of CB 1 and CB2 receptors and treat conditions mediated by these receptors.

Abstract translation: 公开了式（I）的呋喃并吡啶大麻素类似物化合物。 这些化合物可用于修饰CB 1和CB 2受体的活性并治疗由这些受体介导的病症。

公开(公告)号：WO2010045377A3

公开(公告)日：2010-08-26

申请号：PCT/US2009060702

申请日：2009-10-14

Applicant: UNIV TENNESSEE RES FOUNDATION ,  MOORE BOB M ,  GURLEY STEVEN ,  MUSTAFA SUNI ,  ALLISON PATRICK

Inventor： MOORE BOB M ,  GURLEY STEVEN ,  MUSTAFA SUNI ,  ALLISON PATRICK

IPC: C07D401/04 ,  A61K31/506 ,  A61P35/00 ,  C07D239/02 ,  C07D239/42 ,  C07D401/02

CPC classification number: C07D241/16 ,  C07D207/36 ,  C07D241/18 ,  C07D409/06

Abstract: Disclosed are compounds of the formula (I): wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.

Abstract translation: 公开了式（I）的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。

公开(公告)号：WO2010045379A2

公开(公告)日：2010-04-22

申请号：PCT/US2009/060706

申请日：2009-10-14

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE ,  GURLEY, Steven ,  MUSTAFA, Suni ,  MOORE, Bob, M

Inventor： GURLEY, Steven ,  MUSTAFA, Suni ,  MOORE, Bob, M

IPC: C07D239/52 ,  C07D213/69 ,  A61K31/505 ,  A61K31/44 ,  A61P35/00

CPC classification number: C07D409/06 ,  A61K31/44 ,  A61K31/505 ,  C07D213/69

Abstract: Disclosed are compounds of the formula (I): wherein R 1 , R 2 , V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.

Abstract translation: 公开了式（I）的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。

公开(公告)号：WO2009143183A1

公开(公告)日：2009-11-26

申请号：PCT/US2009/044561

申请日：2009-05-19

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE ,  MOORE, Bob, M., II ,  GURLEY, Steven ,  MUSTAFA, Suni ,  ALLISON, Patrick

Inventor： MOORE, Bob, M., II ,  GURLEY, Steven ,  MUSTAFA, Suni ,  ALLISON, Patrick

IPC: A01N43/54 ,  A61K31/505 ,  C07D239/42

CPC classification number: C07D239/52 ,  C07D409/06 ,  C07D409/14

Abstract: Disclosed are compounds of the following formula (I); wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.

Abstract translation: 公开了下式（I）的化合物; 其中R1，R2，V，W，X，Y和Z可以如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。

公开(公告)号：WO2010045377A2

公开(公告)日：2010-04-22

申请号：PCT/US2009/060702

申请日：2009-10-14

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE ,  MOORE, Bob, M. ,  GURLEY, Steven ,  MUSTAFA, Suni ,  ALLISON, Patrick

Inventor： MOORE, Bob, M. ,  GURLEY, Steven ,  MUSTAFA, Suni ,  ALLISON, Patrick

IPC: C07D401/04 ,  C07D401/02 ,  C07D239/02 ,  C07D239/42 ,  A61K31/506 ,  A61P35/00

CPC classification number: C07D241/16 ,  C07D207/36 ,  C07D241/18 ,  C07D409/06

Abstract: Disclosed are compounds of the formula I: wherein R 1 , R 2 , V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.

Abstract translation: 公开了式I的化合物：其中R 1，R 2，V，W，X，Y和Z可如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。

公开(公告)号：WO2009143182A1

公开(公告)日：2009-11-26

申请号：PCT/US2009/044560

申请日：2009-05-19

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE ,  MOORE, Bob, M., II ,  GURLEY, Steven ,  MUSTAFA, Suni ,  ALLISON, Patrick

Inventor： MOORE, Bob, M., II ,  GURLEY, Steven ,  MUSTAFA, Suni ,  ALLISON, Patrick

IPC: A01N43/16 ,  A61K31/35 ,  A61K31/505

CPC classification number: C07D491/052 ,  C07D491/04

Abstract: Disclosed are compounds of the following formula (I); wherein R1, R2, V, W, X, Y and Z can be as defined herein. The compounds can be used in the treatment of disorders mediated by the cannabinoid receptors.

Abstract translation: 公开了下式（I）的化合物; 其中R1，R2，V，W，X，Y和Z可以如本文所定义。 该化合物可用于治疗由大麻素受体介导的病症。

公开(公告)号：WO2007127384A3

公开(公告)日：2009-04-02

申请号：PCT/US2007010265

申请日：2007-04-26

Applicant: SYMON COMMUNICATIONS INC ,  GURLEY STEVEN L

Inventor： GURLEY STEVEN L

IPC: G06Q30/02 ,  G07G1/14

CPC classification number: H04N5/765 ,  G06Q30/02 ,  H04N5/44543 ,  H04N21/25891 ,  H04N21/4117 ,  H04N21/41415 ,  H04N21/4222 ,  H04N21/4722 ,  H04N21/4758 ,  H04N21/4786 ,  H04N21/4886 ,  H04N21/6181 ,  H04N21/812

Abstract: According to one embodiment of the invention, a method allows user interaction with information presented on electronic video displays. The method provides content for presentation on at least one display in a venue. A text-based message is received, from a venue patron, from a wireless device. The text based message is based upon the content presented on the at least one display in the venue and includes information to modify the content on the at least one display. The text based message is processed and a communication is transmitted to the venue to modify the content on the at least one display or create a memento of the content on the at least one display.

Abstract translation: 根据本发明的一个实施例，一种方法允许用户与电子视频显示器上呈现的信息进行交互。 该方法提供用于在场地中的至少一个显示器上呈现的内容。 从场地顾客接收来自无线设备的基于文本的消息。 基于文本的消息基于呈现在场地中的至少一个显示器上的内容，并且包括用于修改至少一个显示器上的内容的信息。 处理基于文本的消息，并且将通信传送到场地以修改至少一个显示器上的内容，或者在至少一个显示器上创建内容的纪念品。